Duchenne Muscular Dystrophy (DMD)

In Lab Research, Scientists Slow Progression of a Fatal Form of Muscular Dystrophy

In a paper published in the Nature journal Scientific Reports, Saint Louis University researchers report that a new drug reduces fibrosis (scarring) and prevents loss of muscle function in an animal model of Duchenne muscular dystrophy (DMD), providing a promising approach in designing new medications for those suffering from DMD. DMD is a fatal form of

December 9th, 2017|Categories: Around The State, Muscular Dystrophy|Tags: Duchenne Muscular Dystrophy, Duchenne Muscular Dystrophy (DMD)|

Genetically Corrected Stem Cells Spark Muscle Regeneration

Mar. 5, 2013 — Science Daily - Researchers at the University of Minnesota's Lillehei Heart Institute have combined genetic repair with cellular reprogramming to generate stem cells capable of muscle regeneration in a mouse model for Duchenne Muscular Dystrophy (DMD). The research, which provides proof-of-principle for the feasibility of combining induced pluripotent stem cell technology and

March 5th, 2013|Categories: Disease Specific, Muscular Dystrophy|Tags: Duchenne Muscular Dystrophy (DMD), genetic correction, iPSCs, Lillehei Heart Institute, Rita Perlingeiro, University of Minnesota|